Publications by authors named "Lars-Olaf Cardell"

Background: The complexity and heterogeneity of neutrophils are recognized, especially their roles in modulating inflammation and cancer immune responses. The detailed functions of neutrophils in human tumour-draining lymph nodes (TDLNs), specifically in the context of head and neck cancer, remain inadequately characterized.

Aim: This study aims to delineate the phenotypic diversity of neutrophils in TDLNs, non-tumour-draining lymph nodes (nTDLNs) from patients with oral squamous cell carcinoma (OSCC), and to evaluate their correlation with clinical outcomes.

View Article and Find Full Text PDF
Article Synopsis
  • OSCC recurrence and mortality rates remain high despite various treatments, highlighting the need for improved prognostic models and biomarkers, particularly focusing on tumor-draining lymph nodes (TDLNs) and T regulatory cells (Tregs).
  • A study of 49 OSCC patients found that certain immune cell markers in TDLNs, like elevated FoxP3+CD4+ and TIGIT+CD8+ cells, were linked to worse disease-free survival, while high levels of CXCR5+CD4+ cells indicated better outcomes.
  • The research suggests that the expression of immune checkpoints on T cells within TDLNs could serve as critical prognostic biomarkers, pointing towards the potential benefits of using neoadjuvant immunotherapy to enhance
View Article and Find Full Text PDF
Article Synopsis
  • Oral squamous cell carcinoma (OSCC) has a better survival rate when detected early, but prognosis worsens if it spreads to lymph nodes; identifying biomarkers for early detection could improve treatment strategies.
  • The study analyzed dendritic cells and T-cells in tumor-draining lymph nodes from 12 OSCC patients and compared them to 9 benign cases, revealing that certain immune cells in TDLNs show immunosuppressive characteristics and are linked to metastasis.
  • Findings suggest that high PD-L1 expression on dendritic cells in TDLNs may indicate metastatic risk and poorer outcomes, positioning PD-L1 as a potential predictive biomarker for OSCC prognosis.
View Article and Find Full Text PDF
Article Synopsis
  • - ILC2s are important for type 2 immunity and play a role in chronic inflammatory conditions like asthma.
  • - Research shows that resting ILC2s in humans retain a marker (CD45RO) associated with activated inflammatory ILC2s, while also decreasing another typical marker (CD127) in specific tissues.
  • - When isolated and stimulated, these CD127-CD45RO+ ILC2s demonstrate enhanced growth and cytokine production, suggesting that human ILC2s can develop an innate immune memory, prompting a reevaluation of how these cells are identified.
View Article and Find Full Text PDF

Aim: In Sweden, allergy immunotherapy (AIT) is available as either subcutaneous immunotherapy (SCIT) injections or sublingual immunotherapy (SLIT) tablets and is used to treat moderate-severe allergic rhinitis (AR). This study sought to determine direct and indirect annual costs stemming from treatment-related travel, appointments, waiting times and medication costs, before exploring likely CO emission-related cost-savings for 20,330 patients receiving SCIT or SLIT-tablets in Sweden.

Methods: A model was developed in Python to capture each category of costs in the target patient population.

View Article and Find Full Text PDF

Severe chronic rhinosinusitis with nasal polyposis (CRSwNP) is a disabling airway disease that significantly impacts patients' lives through the severity of symptoms, the need for long-term medical treatment and the high risk of recurrence post-surgery. Biological agents targeting type 2 immune responses underlying the pathogenesis of CRSwNP have shown effectiveness in reducing polyp size and eosinophilic infiltrate, and in decreasing the need for additional sinus surgeries. However, despite recent progress in understanding and treating the disease, type 2 inflammation-driven severe CRSwNP continues to pose challenges to clinical management due to several factors such as persistent inflammation, polyp recurrence, heterogeneity of disease, and comorbidities.

View Article and Find Full Text PDF

In Sweden, allergy immunotherapy (AIT) is available as either subcutaneous immunotherapy (SCIT) injections or sublingual immunotherapy (SLIT) tablets and is used to treat moderate-severe allergic rhinitis (AR). This study sought to determine treatment-related CO emissions and travel times in Swedish patients receiving either SCIT or SLIT-tablets. A list of specialized Swedish AR clinics that administer AIT was determined, and respective co-ordinates retrieved.

View Article and Find Full Text PDF

A history of allergies has been said to be associated with a lower risk of head and neck cancer compared to the general population. However, it is not known whether having an allergic sensitization influences the prognosis and advancement of cancer disease. Thus, the aim of the study was to investigate the relationship between allergic sensitization and oral cancer advancement and patient survival.

View Article and Find Full Text PDF

Intramuscular injections with methylprednisolone treating allergic rhinitis (AR) have a long history. Modern guidelines are designed to dissuade this treatment, but it´s frequently used, especially in primary care. This despite of concern for side effects and lack of modern placebo-controlled studies.

View Article and Find Full Text PDF

Cutaneous squamous cell cancer (cSCC) is the second most common form of skin cancer, characterized by abnormal, accelerated growth of squamous cells. When caught early, most cSCCs are curable. About 5 percent of the cSCC cases have advanced to such an extent, generally metastatic, that they are far more dangerous, with very poor prognosis and challenging to treat.

View Article and Find Full Text PDF

Background: Allergic asthma is a heterogeneous disorder involving chronic airway inflammation, reversible airflow limitation, and tissue remodeling, causing chronic airflow limitation. Most of the asthma research has been focused on elucidating the proinflammatory pathways underlying disease pathogenesis. Paradoxically, the necessity of appropriate termination and resolution of inflammation has not been recognized until recently.

View Article and Find Full Text PDF

Background: Allergic rhinitis (AR) is a chronic disease with high prevalence. There are currently many treatments available. However, despite an often good therapeutic response, many patients still report impairment in quality of life (QoL) during the pollen season.

View Article and Find Full Text PDF

The contribution of different immune cell subsets, especially T cells, in anti-tumor immune response is well established. In contrast to T cells, the anti-tumor contribution of B cells has been scarcely investigated. B-cells are often overlooked, even though they are important players in a fully integrated immune response and constitute a substantial fraction of tumor draining lymph nodes (TDLNs) known also as Sentinel Nodes.

View Article and Find Full Text PDF

Background: Sentinel lymph node biopsy (SLNB) is used to improve the staging of and guide treatment in patients with early-stage T1-T2 N0 oral squamous cell carcinoma (OSCC). The role of sentinel nodes (SNs) and the use of SN-technique in advanced OSCC (T3-T4 and/or N+) remain to be evaluated. This study investigates the nodal drainage and the rate of positive SNs (SNs+) in all stages of OSCC.

View Article and Find Full Text PDF
Article Synopsis
  • Chronic rhinosinusitis with nasal polyps (CRSwNP) and asthma often occur together and share similar pathological traits, but healthcare is typically divided by specialties, leading to a need for integrated treatment approaches.
  • A group of 16 experienced physicians in northern Europe discussed ways to improve global airways care through better screening, collaboration, and education among specialties, providing practical recommendations and identifying gaps in research.
  • The findings emphasize the importance of joint management to optimize care for adults with CRSwNP and asthma, suggesting that interdisciplinary clinics could enhance early recognition and treatment across related airway diseases.
View Article and Find Full Text PDF
Article Synopsis
  • Interleukin-26 (IL-26) is produced by immune and structural cells after toll-like receptor (TLR) stimulation and is known to inhibit viral replication and boost neutrophil activity, positioning it as a critical player in lung defense.
  • Research shows that IL-26 levels are significantly elevated in COVID-19 patients and correlate with other inflammatory markers such as IL-8 and TNFα, indicating its role in hyperinflammation.
  • Additionally, higher IL-26 concentrations relate to severe tissue damage markers and hematological changes in COVID-19 patients, suggesting it could be a useful target for diagnosis and treatment strategies.
View Article and Find Full Text PDF

Introduction: High Tregs infiltration within the tumour microenvironment (TME) of various cancers shows a positive correlation with poor prognosis. Despite the fact that tumour draining lymph nodes (TDLNs) are recognized as key organs playing a crucial role in response to immunotherapy and modulating anti-cancer immunity, the distribution of Tregs and their role in TDLNs remain uncertain thus far. The purpose of this project is to investigate the density of Tregs in TDLNs and non-TDLNs and their expression of immune checkpoint molecules - PD-1 and CTLA-4.

View Article and Find Full Text PDF

Despite the introduction of vaccines, COVID-19 still affects millions of people worldwide. A better understanding of pathophysiology and the discovery of novel therapies are needed. One of the cells of interest in COVID-19 is the neutrophil.

View Article and Find Full Text PDF

Introduction: Allergic asthmatics with both an early (EAR) and a late allergic reaction (LAR) following allergen exposure are termed 'dual responders' (DR), while 'single responders' (SR) only have an EAR. Mechanisms that differentiate DR from SR are largely unknown, particularly regarding the role and phenotypes of neutrophils. Therefore, we aimed to study neutrophils in DR and SR asthmatics.

View Article and Find Full Text PDF
Article Synopsis
  • The study aims to highlight a new clinical manifestation of the Omicron variant of SARS-CoV-2, primarily affecting young, vaccinated adults who present with symptoms resembling epiglottitis.
  • Researchers conducted a retrospective analysis of 20 COVID-19 patients at an Ear, Nose, and Throat Emergency Department, identifying symptoms like severe sore throat and fever, with many fully vaccinated individuals involved.
  • Results indicate that the Omicron variant primarily impacts the upper airways, causing acute laryngitis without loss of smell or taste, and underscores the importance of prompt laryngeal exams to rule out serious complications, though none of the patients developed actual epiglottitis.
View Article and Find Full Text PDF

Pneumonia is a global cause of mortality, and this provides a strong incentive to improve the mechanistic understanding of innate immune responses in the lungs. Here, we characterized the involvement of the cytokine interleukin (IL)-26 in bacterial lung infection. We observed markedly increased concentrations of IL-26 in lower airway samples from patients with bacterial pneumonia and these correlated with blood neutrophil concentrations.

View Article and Find Full Text PDF

Objective: To find out if nitric oxide (NO) can be locally produced in the middle ear and if chronic otitis media (COM) and acquired cholesteatoma affect the production.

Design: Case-control study.

Setting: Two tertiary-referral hospitals.

View Article and Find Full Text PDF

Chronic rhinosinusitis with nasal polyps (CRSwNP) is characterized by a chronic inflammatory process often associated with comorbid asthma. In this study, we analyzed the transcriptomes of single T helper (T) cells from nasal polyps of patients with CRSwNP and validated these findings using multiparameter flow cytometry. Polyp tissue contained suppressive T regulatory (T) cells, T2 cells, type 2 innate lymphoid cells, and three transcriptionally distinct subsets of cytotoxic CD4 T cells (CD4 CTL).

View Article and Find Full Text PDF
Article Synopsis
  • - The study investigated whether increasing the dose of intralymphatic immunotherapy (ILIT) for allergic rhinitis could improve safety and effectiveness after standard treatments, comparing two groups of patients with different vaccination backgrounds.
  • - Results showed that while higher doses were generally safe after traditional treatment, they didn't significantly improve symptoms or quality of life, and serious reactions occurred at lower doses in unvaccinated patients.
  • - The findings suggest that high-dose ILIT may benefit patients who still experience symptoms after standard therapy, but caution against exceeding certain dosages in previously unvaccinated individuals.
View Article and Find Full Text PDF